Review





Similar Products

anti fah  (Proteintech)
93
Proteintech anti fah
Anti Fah, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fah/pm41792125-375-40-41?v=Proteintech
Average 93 stars, based on 1 article reviews
anti fah - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
rtta3g  (Addgene inc)
93
Addgene inc rtta3g
Rtta3g, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fah/pm41775935-486-18-22?v=Addgene+inc
Average 93 stars, based on 1 article reviews
rtta3g - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
paav fah rtta3g  (Addgene inc)
93
Addgene inc paav fah rtta3g
Paav Fah Rtta3g, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fah/bio_rxiv__64898__2026__02__08__704617-188-32-33?v=Addgene+inc
Average 93 stars, based on 1 article reviews
paav fah rtta3g - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
female fah  (Jackson Laboratory)
86
Jackson Laboratory female fah
Female Fah, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fah/pmc12893922-484-2-14?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
female fah - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
e coli fah  (Biotechnology Information)
86
Biotechnology Information e coli fah
(A) Screening of commensal and probiotic strains for 3-PPA production. Inset: Polyphenol supplementation inhibited bacterial growth. Mean ± SEM. (B) Chromatogram showing healthy subject isolate <t>E.</t> <t>coli</t> <t>FAH</t> degraded CGA. (C) Colonisation of E. coli FAH raised plasma HIPA levels but not PAGly. FMT: faecal microbiota transplantation using faeces from conventionally raised mice. Mean ± SD; n=4–5. (D) C. sporogenes , B. breve and E. coli FAH converted trans-cinnamic acid to 3-PPA. Mean ± SEM; n=3. (E) Pharmacokinetic profiling of trans-cinnamic acid and related metabolites following oral administration. Mean ± SD; n=3-5. Significance was assessed by two-way ANOVA, with P-values between lines indicating treatment effects. (F-H) Colonization with 3-PPA-producing bacteria increased 3-PPA and HIPA levels in vivo . (F) Study design. Plasma, urinary, and faecal concentrations of 3-PPA (G) and HIPA (H) were assessed following bacterial colonization in vivo . Significance was assessed using the Kruskal– Wallis test followed by pairwise comparisons without correction for multiple testing. Mean ± SD; n=3–6. See also Figure S9.
E Coli Fah, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fah/bio_rxiv__2025__11__25__690607-242-0-9?v=Biotechnology+Information
Average 86 stars, based on 1 article reviews
e coli fah - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
primary antibody against fah  (Yecuris Inc)
90
Yecuris Inc primary antibody against fah
(A) Screening of commensal and probiotic strains for 3-PPA production. Inset: Polyphenol supplementation inhibited bacterial growth. Mean ± SEM. (B) Chromatogram showing healthy subject isolate <t>E.</t> <t>coli</t> <t>FAH</t> degraded CGA. (C) Colonisation of E. coli FAH raised plasma HIPA levels but not PAGly. FMT: faecal microbiota transplantation using faeces from conventionally raised mice. Mean ± SD; n=4–5. (D) C. sporogenes , B. breve and E. coli FAH converted trans-cinnamic acid to 3-PPA. Mean ± SEM; n=3. (E) Pharmacokinetic profiling of trans-cinnamic acid and related metabolites following oral administration. Mean ± SD; n=3-5. Significance was assessed by two-way ANOVA, with P-values between lines indicating treatment effects. (F-H) Colonization with 3-PPA-producing bacteria increased 3-PPA and HIPA levels in vivo . (F) Study design. Plasma, urinary, and faecal concentrations of 3-PPA (G) and HIPA (H) were assessed following bacterial colonization in vivo . Significance was assessed using the Kruskal– Wallis test followed by pairwise comparisons without correction for multiple testing. Mean ± SD; n=3–6. See also Figure S9.
Primary Antibody Against Fah, supplied by Yecuris Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fah/us12357580-615-17-20?v=Yecuris+Inc
Average 90 stars, based on 1 article reviews
primary antibody against fah - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
csr-faha-h2 21k702 1200~1600 -cooh (glcu*)  (Cosmo Bio USA)
90
Cosmo Bio USA csr-faha-h2 21k702 1200~1600 -cooh (glcu*)
(A) Screening of commensal and probiotic strains for 3-PPA production. Inset: Polyphenol supplementation inhibited bacterial growth. Mean ± SEM. (B) Chromatogram showing healthy subject isolate <t>E.</t> <t>coli</t> <t>FAH</t> degraded CGA. (C) Colonisation of E. coli FAH raised plasma HIPA levels but not PAGly. FMT: faecal microbiota transplantation using faeces from conventionally raised mice. Mean ± SD; n=4–5. (D) C. sporogenes , B. breve and E. coli FAH converted trans-cinnamic acid to 3-PPA. Mean ± SEM; n=3. (E) Pharmacokinetic profiling of trans-cinnamic acid and related metabolites following oral administration. Mean ± SD; n=3-5. Significance was assessed by two-way ANOVA, with P-values between lines indicating treatment effects. (F-H) Colonization with 3-PPA-producing bacteria increased 3-PPA and HIPA levels in vivo . (F) Study design. Plasma, urinary, and faecal concentrations of 3-PPA (G) and HIPA (H) were assessed following bacterial colonization in vivo . Significance was assessed using the Kruskal– Wallis test followed by pairwise comparisons without correction for multiple testing. Mean ± SD; n=3–6. See also Figure S9.
Csr Faha H2 21k702 1200~1600 Cooh (Glcu*), supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fah/pmc10474455__mmc1-0-2-0?v=Cosmo+Bio+USA
Average 90 stars, based on 1 article reviews
csr-faha-h2 21k702 1200~1600 -cooh (glcu*) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


(A) Screening of commensal and probiotic strains for 3-PPA production. Inset: Polyphenol supplementation inhibited bacterial growth. Mean ± SEM. (B) Chromatogram showing healthy subject isolate E. coli FAH degraded CGA. (C) Colonisation of E. coli FAH raised plasma HIPA levels but not PAGly. FMT: faecal microbiota transplantation using faeces from conventionally raised mice. Mean ± SD; n=4–5. (D) C. sporogenes , B. breve and E. coli FAH converted trans-cinnamic acid to 3-PPA. Mean ± SEM; n=3. (E) Pharmacokinetic profiling of trans-cinnamic acid and related metabolites following oral administration. Mean ± SD; n=3-5. Significance was assessed by two-way ANOVA, with P-values between lines indicating treatment effects. (F-H) Colonization with 3-PPA-producing bacteria increased 3-PPA and HIPA levels in vivo . (F) Study design. Plasma, urinary, and faecal concentrations of 3-PPA (G) and HIPA (H) were assessed following bacterial colonization in vivo . Significance was assessed using the Kruskal– Wallis test followed by pairwise comparisons without correction for multiple testing. Mean ± SD; n=3–6. See also Figure S9.

Journal: bioRxiv

Article Title: 3-Phenylpropionic acid, a microbiota-derived polyphenol metabolite linked to hippuric acid, ameliorates colitis as a colon-enriched PPAR-γ agonist

doi: 10.1101/2025.11.25.690607

Figure Lengend Snippet: (A) Screening of commensal and probiotic strains for 3-PPA production. Inset: Polyphenol supplementation inhibited bacterial growth. Mean ± SEM. (B) Chromatogram showing healthy subject isolate E. coli FAH degraded CGA. (C) Colonisation of E. coli FAH raised plasma HIPA levels but not PAGly. FMT: faecal microbiota transplantation using faeces from conventionally raised mice. Mean ± SD; n=4–5. (D) C. sporogenes , B. breve and E. coli FAH converted trans-cinnamic acid to 3-PPA. Mean ± SEM; n=3. (E) Pharmacokinetic profiling of trans-cinnamic acid and related metabolites following oral administration. Mean ± SD; n=3-5. Significance was assessed by two-way ANOVA, with P-values between lines indicating treatment effects. (F-H) Colonization with 3-PPA-producing bacteria increased 3-PPA and HIPA levels in vivo . (F) Study design. Plasma, urinary, and faecal concentrations of 3-PPA (G) and HIPA (H) were assessed following bacterial colonization in vivo . Significance was assessed using the Kruskal– Wallis test followed by pairwise comparisons without correction for multiple testing. Mean ± SD; n=3–6. See also Figure S9.

Article Snippet: E. coli FAH was deposited at National Center for Biotechnology Information (NCBI: PRJNA923252).

Techniques: Clinical Proteomics, Transplantation Assay, Bacteria, In Vivo